Not applicableStudy completedNCT00240019
What this trial is testing
Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.
Who this might be right for
Diabetic Nephropathy
Stanford University 30
Showing 20 of 0 results